New offering improves the quality and predictability of clinical development while reducing overall trial costs by up to 25 percent RESEARCH TRIANGLE PARK, NC – Quintiles today announced the launch of ...
This post is sponsored by IMARC Research, Inc. Since the August 2011 release of the draft guidance document by the FDA on a risk-based approach to monitoring, there has been a lot of buzz in the ...
BOSTON--(BUSINESS WIRE)--Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health, today ...
WASHINGTON--(BUSINESS WIRE)--Following meetings with then-Commissioner Scott Gottlieb and senior leadership from the Center for Drug Evaluation and Research on the role of CROs and technology ...
Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Risk Management - ICH E6(R3) and FDA Expectations (Sept 5, 2025)" training has been added to ResearchAndMarkets.com's offering .This ...
Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions. For ...
Bethesda, MD (Oct. 17, 2025) — The American Gastroenterological Association (AGA) today released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor ...
Medtech industry groups said the FDA should use existing regulatory and quality tools to monitor performance, while medical ...
Overview: Smarter AI reduces false alerts, reduces fatigue, and helps teams focus on real financial crime rather than noise. Apparent oversight, expl ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback